CURTIS A PETTAWAY to 5-alpha Reductase Inhibitors
This is a "connection" page, showing publications CURTIS A PETTAWAY has written about 5-alpha Reductase Inhibitors.
Connection Strength
0.311
-
Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence. BJU Int. 2011 Oct; 108(8):1302-8.
Score: 0.098
-
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. J Urol. 2011 Jan; 185(1):126-31.
Score: 0.096
-
Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010 Apr 01; 362(13):1192-202.
Score: 0.092
-
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study. BJU Int. 2012 Apr; 109(8):1162-9.
Score: 0.025